Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T L Roszman

Showing results (21-30 of 70) with videos related to

Pageof 7
Sort By:
Cancer|April 1, 1976
Impairment of rosette-forming T lymphocytes in patients with primary intracranial tumorsW H Brooks, T L Roszman, A S Rogers
Cancer|October 1, 1982
Immunobiology of primary intracranial tumors. VI. Suppressor cell function and lectin-binding lymphocyte subpopulations in patients with cerebral tumorsT L Roszman, W H Brooks, L H Elliott
The Journal of Clinical Investigation|July 1, 1990
Inability of mitogen-activated lymphocytes obtained from patients with malignant primary intracranial tumors to express high affinity interleukin 2 receptorsL H Elliott, W H Brooks, T L Roszman
Journal of Neurosurgery|December 1, 1987
Inhibition of lymphocyte responsiveness by a glial tumor cell-derived suppressive factorT L Roszman, W H Brooks, L H Elliott
Journal of Cellular Physiology|June 1, 1971
Distinctions between rabbit lymph node cell populations responding to primary and secondary injections of keyhole limpet hemocyaninJ D Folds, T L Roszman, A B Stavitsky
Immunology|June 1, 1971
A kinetic and quantitative analysis of antibody and protein synthesis during the primary response to keyhole limpet haemocyaninT L Roszman, J D Folds, A B Stavitsky
Transplant Immunology|January 9, 2001
Daclizumab (Zenapax) inhibits early interleukin-2 receptor signal transduction eventsJ Goebel, E Stevens, K Forrest, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1992
Immunologic disparity in the hypopituitary dwarf mouseR J Cross, J S Bryson, T L Roszman
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1984
Cytokinetic basis for the impaired activation of lymphocytes from patients with primary intracranial tumorsL H Elliott, W H Brooks, T L Roszman
Journal of Neuroimmunology|November 1, 1989
Potentiation of antibody responsiveness after the transplantation of a syngeneic pituitary glandR J Cross, J L Campbell, T L Roszman
Pageof 7

Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Cancer|April 1, 1976
Impairment of rosette-forming T lymphocytes in patients with primary intracranial tumorsW H Brooks, T L Roszman, A S Rogers
Cancer|October 1, 1982
Immunobiology of primary intracranial tumors. VI. Suppressor cell function and lectin-binding lymphocyte subpopulations in patients with cerebral tumorsT L Roszman, W H Brooks, L H Elliott
The Journal of Clinical Investigation|July 1, 1990
Inability of mitogen-activated lymphocytes obtained from patients with malignant primary intracranial tumors to express high affinity interleukin 2 receptorsL H Elliott, W H Brooks, T L Roszman
Journal of Neurosurgery|December 1, 1987
Inhibition of lymphocyte responsiveness by a glial tumor cell-derived suppressive factorT L Roszman, W H Brooks, L H Elliott
Journal of Cellular Physiology|June 1, 1971
Distinctions between rabbit lymph node cell populations responding to primary and secondary injections of keyhole limpet hemocyaninJ D Folds, T L Roszman, A B Stavitsky
Immunology|June 1, 1971
A kinetic and quantitative analysis of antibody and protein synthesis during the primary response to keyhole limpet haemocyaninT L Roszman, J D Folds, A B Stavitsky
Transplant Immunology|January 9, 2001
Daclizumab (Zenapax) inhibits early interleukin-2 receptor signal transduction eventsJ Goebel, E Stevens, K Forrest, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1992
Immunologic disparity in the hypopituitary dwarf mouseR J Cross, J S Bryson, T L Roszman
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1984
Cytokinetic basis for the impaired activation of lymphocytes from patients with primary intracranial tumorsL H Elliott, W H Brooks, T L Roszman
Journal of Neuroimmunology|November 1, 1989
Potentiation of antibody responsiveness after the transplantation of a syngeneic pituitary glandR J Cross, J L Campbell, T L Roszman
Pageof 7